Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Validation of Desogestrel-Containing Oral Contraceptive
NCT05002738Phase 4Completed
- Sponsor
- University of Colorado Denver
- Start
- Sep 2021
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of desogestrel and ethinyl estradiol in contraception, sponsored by University of Colorado Denver. Primary endpoints: Serum Etonogestrel Concentration at 24 hours and Serum Ethinyl Estradiol Concentration at 24 hours. Started Sep 2021; status: completed.
02
Drugs
desogestrelethinyl estradiol
03
Conditions
contraception
Beyond the preview
Go deeper on NCT05002738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05002738.